Exploration of Circulating Tumour Cell (CTC) Biology: A Paradigm Shift in Liquid Biopsy

Overview

Journal Indian J Clin Biochem

Specialty Biochemistry

Date 2021 Apr 19

PMID 33867703

Citations 11

Authors

Anshika Chauhan

Rajandeep Kaur

Sushmita Ghoshal

Arnab Pal

Affiliations

Soon will be listed here.

Abstract

Circulating tumour cells (CTCs), are disseminated tumour cells found in the blood in solid tumour malignancies. Identification of CTCs act as emerging tools in the field of the Liquid Biopsy. Majority of the studies focused on detection and enumeration of CTCs due to technological challenges those results from the rarity of CTCs in the blood. Enumeration of CTCs has already proven their value as prognostic as well as predictive biomarkers for disease prognosis. However, recent advances in technology permitted to study the molecular and functional features of CTCs and these features have the potential to change the diagnostic, prognostic and predictive landscape in oncology. In this review, we summarize the paradigm shift in the field of liquid biopsy-based cancer diagnostics using CTC isolation and detection. We have discussed recent advances in the technologies for molecular characterization of CTCs which have aided a shift from CTC enumeration to an in-depth analysis of the CTC genome, transcriptomes, proteins, epigenomes along with various functional features. Finally, as a prognosticating strategy, the potentials of CTCs as a tool of liquid biopsy to predict micrometastasis, monitor prognosis and how to use them as an additional tool for cancer staging has been discussed.

Citing Articles

Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy.

Li Q, Geng S, Luo H, Wang W, Mo Y, Luo Q Signal Transduct Target Ther. 2024; 9(1):266.

PMID: 39370455 PMC: 11456611. DOI: 10.1038/s41392-024-01953-7.

Liquid Biopsy in the Clinical Management of Cancers.

Ho H, Chung K, Kan C, Wong S Int J Mol Sci. 2024; 25(16).

PMID: 39201281 PMC: 11354853. DOI: 10.3390/ijms25168594.

Prospects of liquid biopsy in the prognosis and clinical management of gastrointestinal cancers.

Mondal D, Shinde S, Sinha V, Dixit V, Paul S, Gupta R Front Mol Biosci. 2024; 11:1385238.

PMID: 38770216 PMC: 11103528. DOI: 10.3389/fmolb.2024.1385238.

The integrated on-chip isolation and detection of circulating tumour cells.

Abusamra S, Barber R, Sharafeldin M, Edwards C, Davis J Sens Diagn. 2024; 3(4):562-584.

PMID: 38646187 PMC: 11025039. DOI: 10.1039/d3sd00302g.

Evaluating circulating tumour cell enrichment techniques to establish an appropriate method for clinical application in glioblastomas.

Barber H, Perks C, Kurian K Front Neurol. 2024; 15:1358531.

PMID: 38481938 PMC: 10932969. DOI: 10.3389/fneur.2024.1358531.

References

Baccelli I, Schneeweiss A, Riethdorf S, Stenzinger A, Schillert A, Vogel V . Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat Biotechnol. 2013; 31(6):539-44. DOI: 10.1038/nbt.2576. View

van Dalum G, Stam G, Scholten L, Mastboom W, Vermes I, Tibbe A . Importance of circulating tumor cells in newly diagnosed colorectal cancer. Int J Oncol. 2015; 46(3):1361-8. DOI: 10.3892/ijo.2015.2824. View

Babayan A, Alawi M, Gormley M, Muller V, Wikman H, McMullin R . Comparative study of whole genome amplification and next generation sequencing performance of single cancer cells. Oncotarget. 2017; 8(34):56066-56080. PMC: 5593545. DOI: 10.18632/oncotarget.10701. View

Ni X, Zhuo M, Su Z, Duan J, Gao Y, Wang Z . Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc Natl Acad Sci U S A. 2013; 110(52):21083-8. PMC: 3876226. DOI: 10.1073/pnas.1320659110. View

Alix-Panabieres C, Mader S, Pantel K . Epithelial-mesenchymal plasticity in circulating tumor cells. J Mol Med (Berl). 2016; 95(2):133-142. DOI: 10.1007/s00109-016-1500-6. View

Antonarakis E, Lu C, Luber B, Wang H, Chen Y, Nakazawa M . Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer. JAMA Oncol. 2015; 1(5):582-91. PMC: 4537351. DOI: 10.1001/jamaoncol.2015.1341. View

Cristofanilli M, Budd G, Ellis M, Stopeck A, Matera J, Miller M . Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004; 351(8):781-91. DOI: 10.1056/NEJMoa040766. View

Lucci A, Hall C, Patel S, Narendran B, Bauldry J, Royal R . Circulating Tumor Cells and Early Relapse in Node-positive Melanoma. Clin Cancer Res. 2020; 26(8):1886-1895. DOI: 10.1158/1078-0432.CCR-19-2670. View

Soler A, Cayrefourcq L, Mazard T, Babayan A, Lamy P, Assou S . Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes. Sci Rep. 2018; 8(1):15931. PMC: 6206091. DOI: 10.1038/s41598-018-34365-z. View

10.

Nakazawa M, Lu C, Chen Y, Paller C, Carducci M, Eisenberger M . Serial blood-based analysis of AR-V7 in men with advanced prostate cancer. Ann Oncol. 2015; 26(9):1859-1865. PMC: 4551160. DOI: 10.1093/annonc/mdv282. View

11.

Balakrishnan A, Koppaka D, Anand A, Deb B, Grenci G, Viasnoff V . Circulating Tumor Cell cluster phenotype allows monitoring response to treatment and predicts survival. Sci Rep. 2019; 9(1):7933. PMC: 6538674. DOI: 10.1038/s41598-019-44404-y. View

12.

Gorges T, Kuske A, Rock K, Mauermann O, Muller V, Peine S . Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells. Clin Chem. 2016; 62(11):1504-1515. DOI: 10.1373/clinchem.2016.260299. View

13.

Franzen B, Kamali-Moghaddam M, Alexeyenko A, Hatschek T, Becker S, Wik L . A fine-needle aspiration-based protein signature discriminates benign from malignant breast lesions. Mol Oncol. 2018; 12(9):1415-1428. PMC: 6120227. DOI: 10.1002/1878-0261.12350. View

14.

Mayers J, Wu C, Clish C, Kraft P, Torrence M, Fiske B . Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med. 2014; 20(10):1193-1198. PMC: 4191991. DOI: 10.1038/nm.3686. View

15.

Bardelli A, Pantel K . Liquid Biopsies, What We Do Not Know (Yet). Cancer Cell. 2017; 31(2):172-179. DOI: 10.1016/j.ccell.2017.01.002. View

16.

Eyer K, Doineau R, Castrillon C, Briseno-Roa L, Menrath V, Mottet G . Single-cell deep phenotyping of IgG-secreting cells for high-resolution immune monitoring. Nat Biotechnol. 2017; 35(10):977-982. DOI: 10.1038/nbt.3964. View

17.

Mazel M, Jacot W, Pantel K, Bartkowiak K, Topart D, Cayrefourcq L . Frequent expression of PD-L1 on circulating breast cancer cells. Mol Oncol. 2015; 9(9):1773-82. PMC: 5528721. DOI: 10.1016/j.molonc.2015.05.009. View

18.

Vincent Jordan N, Bardia A, Wittner B, Benes C, Ligorio M, Zheng Y . HER2 expression identifies dynamic functional states within circulating breast cancer cells. Nature. 2016; 537(7618):102-106. PMC: 5161614. DOI: 10.1038/nature19328. View

19.

Amorim M, Valieris R, Drummond R, Pizzi M, Freitas V, Sinigaglia-Coimbra R . A total transcriptome profiling method for plasma-derived extracellular vesicles: applications for liquid biopsies. Sci Rep. 2017; 7(1):14395. PMC: 5663969. DOI: 10.1038/s41598-017-14264-5. View

20.

Hou Y, Guo H, Cao C, Li X, Hu B, Zhu P . Single-cell triple omics sequencing reveals genetic, epigenetic, and transcriptomic heterogeneity in hepatocellular carcinomas. Cell Res. 2016; 26(3):304-19. PMC: 4783472. DOI: 10.1038/cr.2016.23. View